These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 35640802)

  • 1. Active targeting redox-responsive mannosylated prodrug nanocolloids promote tumor recognition and cell internalization for enhanced colon cancer chemotherapy.
    Gao Y; Qiu W; Liang M; Ma X; Ye M; Xue P; Kang Y; Deng J; Xu Z
    Acta Biomater; 2022 Jul; 147():299-313. PubMed ID: 35640802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy.
    Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K
    J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox/pH dual-stimuli responsive camptothecin prodrug nanogels for "on-demand" drug delivery.
    Qu Y; Chu B; Wei X; Lei M; Hu D; Zha R; Zhong L; Wang M; Wang F; Qian Z
    J Control Release; 2019 Feb; 296():93-106. PubMed ID: 30664976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox-responsive nanoparticles based on Chondroitin Sulfate and Docetaxel prodrug for tumor targeted delivery of Docetaxel.
    Li Y; Chen X; Ji J; Li L; Zhai G
    Carbohydr Polym; 2021 Mar; 255():117393. PubMed ID: 33436222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid.
    Yin S; Huai J; Chen X; Yang Y; Zhang X; Gan Y; Wang G; Gu X; Li J
    Acta Biomater; 2015 Oct; 26():274-85. PubMed ID: 26300335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A redox-responsive dihydroartemisinin dimeric nanoprodrug for enhanced antitumor activity.
    Li Y; Pei Q; Cui B; Zhang H; Han L; Li W; Zhu W; Feng X; Xie Z
    J Nanobiotechnology; 2021 Dec; 19(1):441. PubMed ID: 34930288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversibly "double locked" hydroxycamptothecin prodrug nanoparticles for targeted chemotherapy of lung cancer.
    Zhang J; Wang B; Wang H; Wang Z; Zhang P; Huang X; Qian H; Huang D; Chen W; Zhong Y
    Acta Biomater; 2023 Aug; 166():593-603. PubMed ID: 37220820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RGD peptide modified platinum nanozyme Co-loaded glutathione-responsive prodrug nanoparticles for enhanced chemo-photodynamic bladder cancer therapy.
    Hao Y; Chen Y; He X; Han R; Yang C; Liu T; Yang Y; Liu Q; Qian Z
    Biomaterials; 2023 Feb; 293():121975. PubMed ID: 36580720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic core crosslinked camptothecin prodrug micelles with reduction sensitivity and boronic acid-mediated enhanced endocytosis: An intelligent tumor-targeted delivery nanoplatform.
    Huang Y; Zhang W; Xu Y; Zhu S; Wu Y; Chen T; Xiao Y; Lu W; Zhang X; Yu J
    Int J Pharm; 2020 Apr; 580():119250. PubMed ID: 32209369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy.
    Sun B; Luo C; Yu H; Zhang X; Chen Q; Yang W; Wang M; Kan Q; Zhang H; Wang Y; He Z; Sun J
    Nano Lett; 2018 Jun; 18(6):3643-3650. PubMed ID: 29726685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox-Responsive and Dual-Targeting Hyaluronic Acid-Methotrexate Prodrug Self-Assembling Nanoparticles for Enhancing Intracellular Drug Self-Delivery.
    Zhang Y; Li Y; Tian H; Zhu Q; Wang F; Fan Z; Zhou S; Wang X; Xie L; Hou Z
    Mol Pharm; 2019 Jul; 16(7):3133-3144. PubMed ID: 31198046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocytosis-mediated triple-activable prodrug nanotherapeutics potentiating therapeutic efficacy and security towards solid tumors.
    Fu S; Ma S; Peng X; Qiao H; Zang W; Ye J; Zang W; Li M; Shi K; Ye X; Sun W; Zhai Y
    Colloids Surf B Biointerfaces; 2022 Oct; 218():112723. PubMed ID: 35932558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targeting.
    Liu Y; Li D; Guo X; Xu H; Li Z; Zhang Y; Song C; Fan R; Tang X; Zhang Z
    Int J Nanomedicine; 2017; 12():2227-2242. PubMed ID: 28356739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferrin receptor-targeted redox/pH-sensitive podophyllotoxin prodrug micelles for multidrug-resistant breast cancer therapy.
    Li Y; Chen M; Yao B; Lu X; Zhang X; He P; Vasilatos SN; Ren X; Bian W; Yao C
    J Mater Chem B; 2019 Oct; 7(38):5814-5824. PubMed ID: 31495855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A robust strategy for preparation of sequential stimuli-responsive block copolymer prodrugs via thiolactone chemistry to overcome multiple anticancer drug delivery barriers.
    Ke W; Yin W; Zha Z; Mukerabigwi JF; Chen W; Wang Y; He C; Ge Z
    Biomaterials; 2018 Feb; 154():261-274. PubMed ID: 29149720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
    Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
    Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
    Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
    Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
    Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
    Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor redox heterogeneity-responsive prodrug nanocapsules for cancer chemotherapy.
    Wang J; Sun X; Mao W; Sun W; Tang J; Sui M; Shen Y; Gu Z
    Adv Mater; 2013 Jul; 25(27):3670-6. PubMed ID: 23740675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy.
    Ruttala HB; Chitrapriya N; Kaliraj K; Ramasamy T; Shin WH; Jeong JH; Kim JR; Ku SK; Choi HG; Yong CS; Kim JO
    Acta Biomater; 2017 Nov; 63():135-149. PubMed ID: 28890258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.